Coya Therapeutics, Inc.

NASDAQ:COYA

Biotechnology

Healthcare
$2.98 -3.18%

-$0.16 today

Market cap
$69.90M
Beta
0.62
P/E (TTM)
-3.9
EPS (TTM)
-$1.26
52W Low $3.71High $7.75

Volume 0.07M

Average 0.16M

Balance Sheet

Inspect the capital base behind the business.

Assets

$49.95M

FY 2025 · Annual

+12.6% YoY

Liabilities

$6.92M

FY 2025 · Annual

+45.1% YoY

Equity

$43.03M

FY 2025 · Annual

+8.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents4.34M5.93M32.63M38.34M46.82M
Short-term Investments00000
Net Receivables007.5M730.58K0
Inventory00000
Other Current Assets00000
Total Current Assets4.58M7.18M41.2M44.31M49.94M
Property, Plant & Equipment (Net)120.67K93.31K65.95K38.59K11.23K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets87.18K1.12M000
Total Non-current Assets207.85K1.21M65.95K38.59K11.23K
Total Assets4.79M8.4M41.26M44.35M49.95M
Account Payables857.57K1.82M1.16M1.59M1.06M
Short-term Debt00000
Tax Payables00723.85K00
Deferred Revenue00923.11K848.29K1.2M
Other Current Liabilities00000
Total Current Liabilities1.15M3.82M5.05M3.82M5.87M
Long-term Debt012.97M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00574.69K945.45K1.05M
Other Non-current Liabilities00000
Total Non-current Liabilities012.97M574.69K945.45K1.05M
Total Liabilities1.15M16.79M5.63M4.77M6.92M
Common Stock2592591.44K1.67K2.09K
Retained Earnings(5.62M)(17.87M)(25.86M)(40.74M)(61.96M)
Accumulated OCI00000
Other Stockholders Equity00(11.25K)00
Minority Interest00000
Total Equity3.64M(8.39M)35.64M39.58M43.03M
Total Debt012.97M000
Net Debt(4.34M)7.03M(32.63M)(38.34M)(46.82M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$50.7M
Other Current$2.5M
Total Current Assets$53.3M
PP&E (Net)$8.4M
Other Non-current-$8.4M
Total Non-current Assets$8.4K
Total Assets$53.3M

Analysis

Selected assets total $53.3M for Latest. The largest visible component is Cash & Equivalents at $50.7M, about 95.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportOct 14, 2026
8-KCurrent reportOct 5, 2026
8-KCurrent reportSep 15, 2026

How much cash does COYA have?

Coya Therapeutics, Inc. (COYA) reported $46.82M in cash and equivalents in fiscal 2025.

How much debt does COYA carry?

Coya Therapeutics, Inc. (COYA) reported $0.00 of total debt, with net debt of -$46.82M.